Research Overview
New Reimbursement Systems for Homecare and Non-hospital Devices Encourage Hospitals to Reassess their Patient-handling Procedures
Reimbursement schemes for healthcare in Europe are complex as they differ across countries. Some schemes credit patients with cash, which they can use for treatments, therapies, devices, or as payments for healthcare staff that aid them in their own homes. Meanwhile, others provide payment for managed care, wherein the healthcare trusts have continued responsibility of the patient. Innovations in reimbursement policies such as the diagnosis-related groups (DRGs) have helped reduced the period of hospital stays. Since under this scheme, hospitals are paid a flat rate fee dependant of the disease instead of the duration of hospital stay, they have to offer the most cost-effective, resource-efficient means of continued treatment and care. The widespread adoption of DRG reimbursement systems across Europe has cut into the revenues generated from in-patient treatments and has instead increased those earned from homecare and non-hospital-managed therapies.
This series of Frost & Sullivan research services analyses the homecare and non-hospital devices markets in Benelux (Belgium, Luxemburg and the Netherlands), France, Germany, Italy, Scandinavia (Denmark, Finland, Norway and Sweden), Spain as well as the United Kingdom. The studies discuss major industry challenges as well as market drivers and restraints along with providing a comprehensive analysis of the markets. They segment the markets by product type into respiratory and infusion therapy devices as well as incontinence-management products.
Smaller Companies Need to Introduce Novel Technologies to Survive
Currently, the factors in the homecare and non-hospital devices markets are favourable to mergers and acquisitions and this puts tremendous pressure on small companies to stay afloat. To avoid being acquired by bigger companies, these enterprises need to offer novel technologies, lower pricing strategies or excellent service packages.
Small companies need to provide advanced solutions such as wireless technology, which facilitates remote patient monitoring and telemedicine by enabling data transfer, processing, storage and networking services. "Patients are more receptive to using homecare and non-hospital devices if they have in-built, wireless monitoring capabilities," says the analyst of this research service. "Vendors can also increase their acceptance by ensuring that the devices do not impinge on normal day-to-day life."
Exciting Developments in the Market Attract an Increasing Number of Users, Offsetting Reduced Margins
Reduced product prices along with healthcare budgetary restraints have narrowed the already slim profits, sparking concerns about maintaining steady revenue streams in the homecare and non-hospital devices markets. However, there are hopes of revenue revival with companies increasingly investing in research and development and thereby, stimulating interest as well as demand for advanced products.
"With companies producing dedicated products for use by nursing staff, care givers and patients themselves, healthcare professionals are increasingly trusting their safety, suitability and effectiveness," notes the analyst. "Many homecare and non-hospital devices have user-friendly interfaces and computer-aided therapy, which ensures coordinated and controlled disease management." Such benefits are expected to significantly improve the adoption rates of these systems.
Frost & Sullivan Growth Partnership Service
Based on extensive and in-depth research, real-world consulting work, and new theories tested in hundreds of companies across many industries, Frost & Sullivan has evolved its Growth Partnership Services (GPS) program that provides established and emerging firms with powerful growth visions. Moving beyond token mission statements, GPS provides an actionable vision to growth consulting partners by illustrating how key intelligence and strategic research based on defined goals can guide day-to-day behavior and overall company direction. The foundation of Frost & Sullivan's GPS includes:
- Assisting companies to reach their full potential in the core business
- Providing growth strategies to help companies expand into related businesses
- Preemptively redefining the core business during market turbulence
- Applying the Frost & Sullivan framework to identify and address common mistakes resulting from misaligned corporate strategies
- Recommending growth management strategies through continuous partnership
To maximize the potential for growth within a firm's internal and external environment, Frost & Sullivan consultants can facilitate the creation of strategic programs that deliver improved market success. Frost & Sullivan's strengths lie in combining strategic understanding with market expertise and applying these with absolute commitment to its clients' growth.
Benefits of this Service
Introduction to the European Homecare and Non-hospital Devices Markets
This research service introduces the European homecare and non-hospital devices market and discusses the market segments of respiratory and infusion therapy devices as well as incontinence management products.
SMART Analysis for Homecare and Non-hospital Device Opportunities in France, Germany, Italy, Spain and the United Kingdom
The simple multi-attribute research technique (SMART) is a statistical analysis model that has been used by Frost & Sullivan to identify attractive markets in Europe. It involves the weighing of multiple attributes and analysing each country's response to the cumulative of all the attributes. This has been carried out for the homecare and non-hospital devices markets in Europe.
Strategic Analysis and Recommendations for Companies in the European Homecare and Non-hospital Devices Markets
This research service offers strategic recommendations with an entry strategy analysis and discusses tactics to overcome industry challenges.
Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:
- Respiratory therapy devices
- Infusion therapy devices
- Incontinence management products
What's Included
- Overview of the European homecare and non-hospital devices markets
- Market drivers and restraints as well as industry challenges
- Simple multi-attribute research technique (SMART) analysis assessing the opportunities available in France, Germany, Italy, Spain and the United Kingdom
| 
View Cart
